Cover image of the article: Nitric Oxide production following vaccination with killed mycobacterium Tuberculosis (H37Rv) and BCG

Image Credit:J Inflamm Dis

Nitric Oxide production following vaccination with killed mycobacterium Tuberculosis (H37Rv) and BCG

Authors

A Aghaiei, A Zavaran Hosseni,*, SM. Moazzeni
*Corresponding Author: Email: azavaranhosseni@mail.com

Journal of Inflammatory Diseases:Vol. 6, issue 3; 22-29
Published online:Dec 31, 2002
Article type:Research Article
How to Cite:Aghaiei A, Zavaran Hosseni A, Moazzeni S. Nitric Oxide production following vaccination with killed mycobacterium Tuberculosis (H37Rv) and BCG. J Inflamm Dis. 2024;6(3):e154886. doi:

Abstract

Abstract Background: Protective immune response induced by viable BCG has been suggested by several investigators. Both killed BCG and Mycobacterium tuberculosis are able to induce response. Nitric oxide (NO) is one of the non-specific responses produced against these agents. Objective: To survey the effect of a live, killed BCG and also killed Mycobacterium tuberculosis (H37Rv strain) on NO production. Methods: 6-8-week-old female BALB/c mice were used. Three groups were vaccinated with viable, killed BCG and killed Mtb, respectively. One group received PBS as a control. After 5-8 weeks of vaccination, peritoneal cells of all groups were collected in usual manner and plated out in 96-well plates. Cells were treated with killed H37Rv, killed BCG and viable BCG alone or with rIFN? and NO inhibitors (Aminoguanidine and NGMA). Supernatant of each well was collected after 24h. NO level was estimated by Griess method by ELISA reader at 540nm absorbance. Findings: Results indicated that NO induction level in vaccinated groups were higher than control (P?0.05). Among vaccinated groups, those vaccinated with Mtb produced more NO than the others. Conclusion: Killed Mtb was more potent than the others and should be considered in any planning of new vaccine in term of NO release.

Highlights

Copyright

© 2024, Journal of Inflammatory Diseases. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.

Similar Articles

30
May
2016
Effects of Mycobacterium tuberculosis ESAT6-CFP10 Protein on Cell Viability and Production of Nitric Oxide in Alveolar Macrophages

Effects of Mycobacterium tuberculosis ESAT6-CFP10 Protein on Cell Viability and Production of Nitric Oxide in Alveolar Macrophages

Xiaoli Xie,
Meng Han,
Liang Zhang,
Laixing Liu,
Zuye Gu,
Mei Yang
,et al.

Xie X, Han M, Zhang L, Liu L, Gu Z, et al. Effects of Mycobacterium tuberculosis ESAT6-CFP10 Protein on Cell Viability and Production of Nitric Oxide in Alveolar Macrophages. Jundishapur J Microbiol. 2016;9(6):e33264. doi: https://doi.org/10.5812/jjm.33264

31
Mar
2014
Comparison of in vivo and in vitro methods for potency assay of Bordetella Pertussis vaccines

Comparison of in vivo and in vitro methods for potency assay of Bordetella Pertussis vaccines

SH mousavi,
E asli,
A movahedi,
N harzandi,
V maljaee

mousavi S, asli E, movahedi A, harzandi N, maljaee V. Comparison of in vivo and in vitro methods for potency assay of Bordetella Pertussis vaccines. J Inflamm Dis. 2024;17(6):e155803. doi:

26
Jan
2015
Susceptibility Pattern of Bacille Calmette-Guerin Strains Against Pyrazinamide and Other Major Anti-Mycobacterial Drugs

Susceptibility Pattern of Bacille Calmette-Guerin Strains Against Pyrazinamide and Other Major Anti-Mycobacterial Drugs

Seyed Alireza Fahimzad,
Mahmood Ghasemi,
Farideh Shiva,
Keyghobad Ghadiri,
Masoumeh Navidinia,
Abdollah Karimi

Fahimzad SA, Ghasemi M, Shiva F, Ghadiri K, Navidinia M, et al. Susceptibility Pattern of Bacille Calmette-Guerin Strains Against Pyrazinamide and Other Major Anti-Mycobacterial Drugs. Arch Pediatr Infect Dis. 2015;3(1 TB):e17814. doi: https://doi.org/10.5812/pedinfect.17814

17
Jun
2019
Co-administration and Evaluation of Immune Responses of Three DNA Vaccines Encoding Immunogenic Antigens from Mycobacterium tuberculosis

Co-administration and Evaluation of Immune Responses of Three DNA Vaccines Encoding Immunogenic Antigens from Mycobacterium tuberculosis

Hadi Peeridogaheh,
Roghayeh Teimourpour,
Shahram Habibzadeh,
Jafar Mohammadshahi,
Aida Gholoobi,
Amir Teimourpour
,et al.

Peeridogaheh H, Teimourpour R, Habibzadeh S, Mohammadshahi J, Gholoobi A, et al. Co-administration and Evaluation of Immune Responses of Three DNA Vaccines Encoding Immunogenic Antigens from Mycobacterium tuberculosis. Arch Clin Infect Dis. 2019;14(3):e79496. doi: https://doi.org/10.5812/archcid.79496

25
Jan
2015
New Advances in Diagnosis of Latent Tuberculosis Infection: A Review Article

New Advances in Diagnosis of Latent Tuberculosis Infection: A Review Article

Masoud Mardani,
Zahra Abtahian

Mardani M, Abtahian Z. New Advances in Diagnosis of Latent Tuberculosis Infection: A Review Article. Arch Pediatr Infect Dis. 2015;3(1 TB):e22368. doi: https://doi.org/10.5812/pedinfect.22368

More by these authors

A AghaieiPubMedScholar
A Zavaran HosseniPubMedScholar
SM. MoazzeniPubMedScholar
Share
Cited by
Metrics